FDA Inspection 1240380 — Annick Desjardins, MD
The FDA completed an inspection of Annick Desjardins, MD on May 8, 2024 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 8, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Durham, NC (United States)
Additional details
Sponsor-Investigator (S-I)